Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Osiris Therapeutics (OSIR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 251,724
  • Shares Outstanding, K 34,530
  • Annual Sales, $ 59,870 K
  • Annual Income, $ -1,790 K
  • 36-Month Beta 0.84
  • Price/Sales 3.00
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 12/30/16
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.6200 +22.78%
on 12/20/17
7.7100 -10.51%
on 01/16/18
+1.0500 (+17.95%)
since 12/19/17
3-Month
4.2000 +64.29%
on 10/23/17
7.7100 -10.51%
on 01/16/18
+2.7000 (+64.29%)
since 10/19/17
52-Week
2.6700 +158.43%
on 03/15/17
7.7100 -10.51%
on 01/16/18
+1.9900 (+40.53%)
since 01/19/17

Most Recent Stories

More News
SEC Charges Biotech Company, Executives With Accounting Fraud

The Securities and Exchange Commission today charged a Maryland-based biotech company and four former top executives with prioritizing revenue growth over lawful accounting and misleading investors in...

OSIR : 6.9000 (-5.35%)
Osiris Therapeutics, Inc. Announces Resolution of SEC Investigation

Osiris Therapeutics, Inc. (OTC Pink:OSIR) (the "Company"), a leading regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, today announced...

OSIR : 6.9000 (-5.35%)
Osiris Announces a Peer-Reviewed Publication of a Scientific Study Reporting Antimicrobial Properties of Human Cryopreserved Viable Amniotic Membrane

Osiris Therapeutics, Inc. (Pink Sheets:OSIR), a leading regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, announced today a scientific...

OSIR : 6.9000 (-5.35%)
Tecan initiates succession process for the Board of Directors

Tecan Group AG / Tecan initiates succession process for the Board of Directors . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement....

NVIV : 0.69 (unch)
TCHBF : 213.9500 (unch)
OSIR : 6.9000 (-5.35%)
PKI : 80.86 (+1.66%)
CBM : 56.30 (+0.54%)
Osiris Announces a Peer-Reviewed Publication Reporting the Use of Placental Membranes for Refractory Cutaneous Sinus Tracts of Surgical Origin

Osiris Therapeutics, Inc. (Pink Sheets:OSIR), a leading regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, announced today that...

OSIR : 6.9000 (-5.35%)
51.3% Return Seen to Date on SmarTrend Osiris Therapeut Call (OSIR)

SmarTrend identified an Uptrend for Osiris Therapeut (NASDAQ:OSIR) on March 23rd, 2017 at $4.00. In approximately 5 months, Osiris Therapeut has returned 51.25% as of today's recent price of $6.05.

OSIR : 6.9000 (-5.35%)
Soft Tissue Allografts Market to be worth US$6.2 Billion by 2025: Increased Dental Implants and Cosmetic Surgeries Driving Demand, Notes TMR

A fresh study by Transparency Market Research (TMR) notifies that the global soft tissue allografts market was dominated by Allergan, plc. in 2016, and the company is poised to sustain its strong market...

GMED : 43.50 (+1.02%)
SAUHF : 726.5500 (+0.91%)
AGN : 181.33 (+0.94%)
OSIR : 6.9000 (-5.35%)
CNMD : 56.49 (+1.31%)
Osiris Therapeut Shares Up 51.3% Since SmarTrend's Buy Recommendation (OSIR)

SmarTrend identified an Uptrend for Osiris Therapeut (NASDAQ:OSIR) on March 23rd, 2017 at $4.00. In approximately 5 months, Osiris Therapeut has returned 51.25% as of today's recent price of $6.05.

OSIR : 6.9000 (-5.35%)
Osiris Therapeut Has Returned 67.5% Since SmarTrend Recommendation (OSIR)

SmarTrend identified an Uptrend for Osiris Therapeut (NASDAQ:OSIR) on March 23rd, 2017 at $4.00. In approximately 4 months, Osiris Therapeut has returned 67.50% as of today's recent price of $6.70.

OSIR : 6.9000 (-5.35%)
Shares of OSIR Up 70.5% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Osiris Therapeut (NASDAQ:OSIR) on March 23rd, 2017 at $4.00. In approximately 4 months, Osiris Therapeut has returned 70.50% as of today's recent price of $6.82.

OSIR : 6.9000 (-5.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Key Turning Points

2nd Resistance Point 7.4333
1st Resistance Point 7.1667
Last Price 6.9000
1st Support Level 6.7667
2nd Support Level 6.6333

See More

52-Week High 7.7100
Last Price 6.9000
Fibonacci 61.8% 5.7847
Fibonacci 50% 5.1900
Fibonacci 38.2% 4.5953
52-Week Low 2.6700

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.